Loading resource…

Manon Allaire, Tamar Taddei, Dominique Thabut, Guadalupe Garcia-Tsao
Cirrhosis and hepatocellular carcinoma (HCC) are significant outcomes of chronic liver disease, with portal hypertension influencing both conditions. Current guidelines treat these issues separately, leading to inadequate risk stratification and treatment selection. This review advocates for an integrated, stage-based management approach that considers clinically significant portal hypertension as a critical factor in treatment decisions. It highlights the need for future research to validate non-invasive assessments of portal hypertension in HCC management.
No account needed